Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer.
Floor of mouth
Gum
Human papilloma virus
Oral cancer
Oral cavity
Palate
Tongue
Journal
Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
06
07
2021
revised:
25
08
2021
accepted:
27
08
2021
pubmed:
13
9
2021
medline:
15
12
2021
entrez:
12
9
2021
Statut:
ppublish
Résumé
The aim of this study was to investigate the relationship between high-risk genotypes of Human Papilloma Virus (HPV) and cancer of different subsites of the oral cavity. A pooled analysis of five studies included on the International Head and Neck Cancer Epidemiology (INHANCE) Consortium was conducted. HPV 16 and HPV 18 were considered. Adjusted odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for HPV and each oral cavity subsites were simultaneously estimated using multinomial logistic regression models. The analysis included 1157 cases and 3272 controls. This study showed a slightly higher prevalence of HPV infection among oral cancer cases than controls. In particular, an increased risk of other and not otherwise specified (NOS) sites within the oral cavity, oral tongue, palate and floor of mouth cancer was observed for overall HPV16 positivity (OR = 1.66, 95 % CI: 1.01-2.72; OR = 1.97, 95 % CI: 1.36-2.85; OR = 2.48, 95 % CI: 1.50-4.11; OR = 2.71, 95 % CI: 1.06-6.95, respectively). In particular, HPV16E7 was related to cancer of floor of mouth, oral cavity NOS and palate (OR = 2.71, 95 % CI: 1.06-6.95; OR = 3.32, 95 % CI:1.53-7.19; OR = 3.34, 95 % CI:1.38-8.06). Results were inconsistent for HPV18 due to low prevalence of infection. Our study suggests that HPV16 infection may increase the risk of developing floor of mouth, gum, tongue, and palate cancers. Subjects with HPV infection have a higher risk of cancer from all sites of the oral cavity.
Sections du résumé
BACKGROUND
The aim of this study was to investigate the relationship between high-risk genotypes of Human Papilloma Virus (HPV) and cancer of different subsites of the oral cavity.
MATERIAL AND METHODS
A pooled analysis of five studies included on the International Head and Neck Cancer Epidemiology (INHANCE) Consortium was conducted. HPV 16 and HPV 18 were considered. Adjusted odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) for HPV and each oral cavity subsites were simultaneously estimated using multinomial logistic regression models.
RESULTS
The analysis included 1157 cases and 3272 controls. This study showed a slightly higher prevalence of HPV infection among oral cancer cases than controls. In particular, an increased risk of other and not otherwise specified (NOS) sites within the oral cavity, oral tongue, palate and floor of mouth cancer was observed for overall HPV16 positivity (OR = 1.66, 95 % CI: 1.01-2.72; OR = 1.97, 95 % CI: 1.36-2.85; OR = 2.48, 95 % CI: 1.50-4.11; OR = 2.71, 95 % CI: 1.06-6.95, respectively). In particular, HPV16E7 was related to cancer of floor of mouth, oral cavity NOS and palate (OR = 2.71, 95 % CI: 1.06-6.95; OR = 3.32, 95 % CI:1.53-7.19; OR = 3.34, 95 % CI:1.38-8.06). Results were inconsistent for HPV18 due to low prevalence of infection.
CONCLUSION
Our study suggests that HPV16 infection may increase the risk of developing floor of mouth, gum, tongue, and palate cancers.
CLINICAL RELEVANCE
Subjects with HPV infection have a higher risk of cancer from all sites of the oral cavity.
Identifiants
pubmed: 34509873
pii: S1877-7821(21)00137-5
doi: 10.1016/j.canep.2021.102020
pii:
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
102020Subventions
Organisme : NCI NIH HHS
ID : R03 CA113157
Pays : United States
Organisme : NIDCR NIH HHS
ID : R03 DE016611
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA048996
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA012609
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA011979
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE013110
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA078609
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100679
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.